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ABSTRACT.
Background: Patient-reported outcome measures (PROMs) are valuable sup-
plements in regular care to facilitate routine monitoring of quality of life from
the patient’s perspective. The 25-item National Eye Institute Visual Function
Questionnaire (NEI-VFQ-25) is a widely used PROM in ophthalmology.
However, the NEI-VFQ-25 is too time-consuming and cumbersome for routine
evaluations in regular care. The aim of this study is to construct a 7-item
questionnaire of which only 3 items are presented to the patient, by means of
routing. This VFQ 3 out of 7 (VFQ-3oo7) should have a minimal loss of
information compared with the NEI-VFQ-25.
Methods: An historical database including 3293 administrations of the NEI-
VFQ-25 was constructed involving patients with retinal detachment, cataract,
corneal diseases, glaucoma, macular degeneration, uveal melanoma and a
normal population sample. The data were subjected to Rasch analyses, in
particular a generalized partial credit model. Items were sorted on the latent trait
and divided into seven categories. From each category, the item with the highest
discriminative value was selected. Through routing, only three out of the seven
remaining questions are used, where the answers navigate patients to a fitting
trait level.
Results: A one-dimensional structure was considered fitting. The VFQ-3oo7
showed a small loss of information compared with the total score of the NEI-
VFQ-25: correlation 0.927 and a relative precision of 0.868.
Conclusion: The very short, but valid, VFQ-3oo7 can be applied to evaluate the
patient’s perceived vision-related health status in routine evaluations of
treatments in regular care, with a small burden for patients.
Key words: patient reported outcome measure – item response theory – Rasch analysis – routine
outcome monitoring – quality of life – ophthalmology
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Introduction
Patient-reported outcome measures
(PROMs) summarize the patients’ per-
ceived functional ability, health and
well-being (Michelotti et al. 2017).
Patient-reported outcome measures
(PROMs) in ophthalmology are con-
sidered a valuable supplement to med-
ical outcomes in (cost)eﬀectiveness
evaluations in clinical trials and quality
improvement at a population level
(Somner et al. 2012; Denniston et al.
2014). Moreover, PROMs can be valu-
able in the consultation room in regu-
lar care to routinely monitor the
patient’s perspective, consequently
stimulating patient participation and
shared clinical decision-making (Boyce
et al. 2014; Fung et al. 2016). With such
routine measurements, PROMs are
also helpful in making the quality of
care more transparent to patients, the
government and ﬁnancing bodies such
as insurers. However, systematic, rou-
tine measurement of PROMs does not
take place in ophthalmology (Miche-
lotti et al. 2017). For such routine use
in regular care, measurement instru-
ments should be short, practical and
useful (Somner et al. 2012). Most of the
available PROMs are valid and reliable
for research, but not for such routine
use (Somner et al. 2012; Michelotti
et al. 2017).
When patients administer PROMs
and other questionnaires on a routine
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basis to systematically provide data on
the quality of treatments in terms of
treatment outcome, this is referred to as
routine outcome monitoring (ROM).
For example, the National Health Ser-
vice introduced in 2009 the routine use of
PROMs for hip surgery, knee surgery,
hernia repair and the treatment of vari-
cose veins. Over 100 000 cases are
administered each year (NHS 2018).
The International Consortium for
Health Outcome Measurement
(ICHOM) provides another example,
aiming to settle an international stan-
dard for routine administration of
PROMs based on the framework devel-
oped at the Harvard Business School by
Michael Porter (ICHOM 2018). In The
Netherlands, healthcare providers and
the ministry of health organized an
online platform in 2017 for the bench-
marking of PROMs (Zorgladder 2018).
All patients administer a set of question-
naires at predetermined points during
the therapy. In all these initiatives, the
aim is to make the quality of treatments
more insightful.
The National Eye Institute Visual
Function Questionnaire (NEI-VFQ-25)
is a widely used patient-reported out-
come measure (PROM) in clinical trials
in Ophthalmology (Mangione et al.
2001). The NEI-VFQ-25 is applied in
many eye disorders, such as cataract,
age-related macular degeneration, dia-
betic retinopathy, retinal detachment,
corneal disease, uveal melanoma, glau-
coma, retinitis and patients with low
vision from any cause. However, the
NEI-VFQ-25 with its current length of
39 items is too time-consuming and
cumbersome for patients for routine
use in regular care. This could particu-
larly be a burden for patients with eye
disorders. First, problems with their
eyesight may cause more diﬃculty in
reading the questionnaires. Second, eye
disorders present themselves mainly in
elderly, who often suﬀer from a signiﬁ-
cant comorbidity. A high comorbidity
may require more follow-up visits and
treatments, with more frequent PROMs
as a consequence.
We targeted to reduce the adminis-
trative burden of the NEI-VFQ-25 and
potentially prevent the phenomenon of
respondent burden. Respondent bur-
den occurs when respondents’ motiva-
tion drops as a result of the length of a
survey and the data quality begins to
deteriorate. The aim of the current
study was to construct a very short
version, suitable for routine use in
regular ophthalmic care with a minimal
loss of information. So, the focus was
to retain the range of the latent trait or
traits as wide as possible while the scale
will still be sensitive for patients with
severe as well as with mild visual
problems.
The current study is not the ﬁrst
attempt to shorten the NEI-VFQ-25,
although our aims were more rigorous in
reducing the number of items, our
methods also diﬀered from those in
previous studies and the range of oph-
thalmic diseases is much broader. Fuku-
hara et al. (2013) constructed an 11-item
short version of the NEI-VFQ-25 using
item response theory also referred to as
Rasch analysis from glaucoma, cataract
and macular degeneration data. They
intended to retain information on all
domains, and therefore included at least
one item on each of these domains. In
another study, by Kowalski et al. (2012),
six items of the NEI-VFQ-25, without
the additional 14 items, were selected,
based on Rasch analysis from glaucoma
and macular oedema data. The item
selection was based on the goodness of
ﬁt of the items. In an iterative procedure,
the ill-ﬁtting items were removed. Also,
Kowalski et al. selected at least one item
per domain. Rasch analysis makes the
assumption of uni-dimensionality. In
2010, Pesudovs reported issues concern-
ing the NEI-VFQ-25 caused by multidi-
mensionality in cataract patients
(Pesudovs et al. 2010). He suggested
using two domains: visual functioning
and a socio-emotional scale.
The operationalization of our aim
was to create the ‘VFQ 3 out of 7’
(VFQ-3oo7), by reducing the NEI-
VFQ-25 to seven items. By using a
smart routing, the patient would only
have to answer 3 of the 7 items, as
items out of the range would not be
presented to the patient. For instance,
if the ﬁrst item already indicated that
the patient had severe visual problems,
items about minor problems would not
be presented.
Methods
The Medical Ethics Committee of the
Erasmus Medical Centre (Rotterdam,
the Netherlands) judged that according
to Dutch law, this study did not require
a formal approval, as the data were
anonymized and had been collected in
previously approved studies.
Study sample
A sample of 2383 patients was collected
from archival data pertaining to vari-
ous eye disorders. Several of our data
sources have been described before:
corneal disease (van Cleynenbreugel
et al. 2014), glaucoma (Islamaj et al.
2018), macular degeneration (Lush-
chyk et al. 2013), uveal melanoma
(van Beek et al. 2018) and retinal
detachment (de Jong et al. 2017). An
exception was the cataract data and
some of the macular degeneration data,
which were both collected in the Rot-
terdam Ophthalmic Institute, but that
had not been published before. The
number of patients and the distribution
of background variables published pre-
viously diﬀered slightly from the data
currently presented, because we used
diﬀerent inclusion and exclusion crite-
ria. We only excluded patients that
failed to ﬁll in the questionnaire. In
order to enhance the generalizability,
we collected an additional sample of
910 people from the general popula-
tion, stratiﬁed for age and gender. In
total, we had 3293 administrations of
the NEI-VFQ-25. The background
variables are described in Table 1.
NEI-VFQ-25
The NEI-VFQ-25 is a vision-speciﬁc
QoL questionnaire consisting of a 25-
item base set of questions and a sup-
plement of 14 additional items measur-
ing vision-related QoL. The NEI-VFQ-
25 can be summarized into a ‘total
component score’ and generates the
following domains: global vision rat-
ing, near activities, distance activities,
limitations in social functioning, role
limitations due to vision, dependency,
mental health, driving, peripheral
vision, colour vision and ocular pain,
ranged from 0 to 100. Most NEI-VFQ-
25 items include ﬁve Likert scale
answer categories. However, 19 items
also include a sixth ‘opting out’ cate-
gory, ‘Stopped doing this for other
reasons or not interested in doing this’,
which is treated as a missing value.
Item selection
In a ﬁrst selection, we excluded items
with more than 10% missing values.
This was a strict criterion, as for the
proposed ‘routing procedure’ (see
below), missing data would have been
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problematic. The previously described
‘opting out’ category caused all of the,
due to missing values, excluded items.
So some items could be dropped
beforehand for contextual reasons, as
they only applied to subgroups of
patients: such as ‘car driving’ or ‘visit-
ing movies, plays, or sports events’ and
an opting out was present. The NEI-
VFQ-25 has two pairs of items which
could be seen as duplicates, namely
item 1 and A1, and item 2 and A2. The
main diﬀerence is that the second of
both deviated in answer categories
compared with all other items, and
was therefore excluded.
Following the recommendations
made by Reeve et al. (2007), we ﬁrst
performed a conﬁrmatory factor anal-
ysis (CFA). In case of a poor ﬁt, a
principal component analysis (PCA)
was performed to check uni-dimension-
ality by the following requirements: (i)
the explained variance of the ﬁrst
component should be at least 40%,
(ii) the ﬁrst eigenvalue should be at
least ﬁve times higher than the second
one and (iii) items should load at least
0.50 on the ﬁrst component. A Monte
Carlo PCA for parallel analysis was
performed as an additional evaluation
of the eigenvalues (Watkins 2006).
Cronbach’s alpha was calculated for
the remaining items, as well as the
person separation and person reliabil-
ity indices. These indices are considered
better suited as a measure of reliability
for Rasch analysis. The person separa-
tion index should be at least 2.0 and the
person reliability at least 0.80 (Linacre
2019). In case the assumption of uni-
dimensionality was not suﬃciently met,
a second dimension would be analysed,
and a second short form VFQ would be
constructed for this dimension. All
items complying with these unidimen-
sional requirements were analysed with
a generalized partial credit model
(gPCM). This is a two parameter
Rasch model for ordered categories.
The gPCM assumes equal diﬀerences
between the answer categories over the
items. This makes an ordering of the
items on the latent trait possible, based
on the item measure, and provides item
diﬀerentiation parameters. Rasch anal-
ysis also allows to express the respon-
dent’s performance on this same latent
trait, the person measure (Embretson
& Reise 2013). The operationalization
of our aim was to create the ‘VFQ 3
out of 7’ (VFQ-3oo7), by reducing the
NEI-VFQ-25 to seven items. Seven
items were deemed suﬃcient for a
broad classiﬁcation in an computerized
administration, where routing reduced
the number of presented items to three.
The selection was done by classifying
the latent variable into seven classes,
and from each class, the best discrim-
inating item was selected for the ﬁnal
version of the VFQ-3oo7 (Figure 1).
Validating VFQ-3oo7
To test the statistical validity of the
VFQ-3oo7, several analyses were per-
formed.
Fit statistics
Inﬁt and outﬁt measures are mean
squares provided by Winsteps, to
detect poorly ﬁtted items. Mean
squares greater than 1.0 indicated an
underﬁt to the model, and mean
squares less than 1.0 indicated an
overﬁt, where values between 0.7 and
1.3 were considered acceptable (Wright
et al. 1994).
Diﬀerential item functioning (DIF)
DIF may occur when a test item does
not have the same relationship to a
latent variable across two or more
groups (Embretson & Reise 2013).
That means that persons from diﬀerent
groups who have the same position on
the latent trait will have a diﬀerent
outcome. In this study, DIF was dis-
cerned for the diﬀerent eye disorders.
For large samples, the DIF t-value is
unduly often signiﬁcant(Tristan 2006).
To compensate for this, we applied the
normalizing procedure described at the
Rasch Organization site, and adjusted
the standard errors with √(N/100).
Multilevel structure
The patient samples included pre-treat-
ment baseline scores and one or more
follow-up measures after treatment. All
these measures were included. This was
not in accordance with the indepen-
dence of measurement assumption.
Generally, this can be overcome by
performing multilevel analyses, the
persons form the upper level, their
repeated measures the lower level.
Table 1. Numbers and participant characteristics.
Population
Retinal
detachment* Cataract*
Corneal
diseases Glaucoma
Macular
degeneration*
Uveal
melanoma Normal Total
Baseline 191 124 81 115 336 111 910 1868
Follow-up 1 58 84 113 285 113 653
Follow-up 2 24 105 110 239
Follow-up 3 51 72 105 228
Follow-up 4 51 80 131
Follow-up 5 37 67 104
Follow-up 6 62 62
Follow-up 7 8 8
Total 249 124 240 493 621 656 910 3293
Gender
Female (%) 53 (31) 68 (56) 52 (62) 55 (46) 212 (63) 54 (48) 456 (50) 950 (51)
Male (%) 118 (69) 53 (44) 32 (38) 65 (54) 125 (37) 59 (52) 454 (50) 906 (49)
Mean age  sd 60.7  13.3 69.9  10.7 72.0  8.3 59.9  9.1 78.7  8.5 60.4  12.7 69.2  11.5 69.1  12.4
VFQ-25 sum score 76.8  17.6 72.1  14.0 73.6  13.2 84.3  11.7 59.2  19.9 81.7  13.3 88.4  9.5 79.6  17.5
sd = standard deviation.
* For some respondents, gender is missing.
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Unfortunately, the IRT program we
applied is not capable of performing
multilevel analyses. Therefore, we
applied a procedure to estimate the
eﬀect of neglecting the multilevel struc-
ture (Mallinson 2011). This procedure
provides a visual presentation of the
deviation caused by the dependency.
Additionally, we preferred a formal test
for the deviation and calculated the
mean absolute diﬀerence (MAD), and
compared this to the standard errors of
the person measures. The MAD then
should be within the 95% conﬁdence
interval of the gPCM person measures,
thus lower than 1.96 times the standard
error. This procedure is described in
more detail in Appendix S1 and Fig.
S1-S5.
Precision
In order to determine the sensitivity
level of the VFQ-3oo7, we used the
relative precision method (McHorney
et al. 1992; Gothwal et al. 2009).
Although Gothwal et al. (2009) applied
F-tests for the calculation of precision,
we preferred random eﬀect models as
these make more eﬃcient use of all
data. We used the data of our largest
longitudinal sample and calculated the
relative precision with the t-values,
with the Likert-score of the VFQ-25
as reference. We excluded the items on
car driving because these were excluded
in the ﬁrst place by Pesudovs et al.
(2010), Kowalski et al. (2012) and
Fukuhara et al. (2013) as well. The
remaining 32 items were Likert scored
and Rasch scored, just as the selection
of the items made by Pesudovs, Kowal-
sky and Fukuhara.
Disorder-speciﬁc analyses
For practical reasons and optimization
of generalizability, one uniform VFQ-
3oo7 is preferred; however, we per-
formed separate analyses for the indi-
vidual disorders, leading to diﬀerent
versions of the VFQ-3oo7. We applied
sensitivity analyses within the various
samples in order to decide whether it is
worthwhile to have diﬀerent versions
for each particular eye disorder.
Routing of the VFQ-3oo7
By using routing, the number of pre-
sented items was reduced to three, as
items out of the range would not be
presented to the patient. For instance,
if the ﬁrst item already indicated that
the patient had severe visual problems,
items about minor problems would not
be presented. For administration, the
ﬁrst item to be ﬁlled in was in the
middle of the latent trait, the second on
a quarter or three quarters, depending
on the answer on the ﬁrst item. The
routing was determined by the medi-
ans. The answer on the second item
determined which of the remaining
four items will be presented as the
third item (Figure 1). To successfully
perform routing, items with more than
10% missing values were excluded in
an earlier stage, as missing data made
routing problematic.
Item weights for calculating the VFQ-3oo7
score
Lastly, in an iterative procedure,
weights for the VFQ-3oo7 score were
determined by applying a maximum
Pearson correlation with the gPCM
measure as criterion. These weights
were rescaled so that, after a logit
transformation, the scores had a range
from 0 to 100, consistent with the range
of the NEI-VFQ-25.
Conﬁrmatory factor analysis (CFA)
was performed with STATA version
15.1 [StataCorp, College Station, Texas
77845 USA], and gPCMwas performed
with Winsteps version 4.1.0 [Linacre, J.
M. (2018). Winsteps Rasch measure-
ment computer program. Beaverton,
Oregon: Winsteps.com]. All other anal-
yses were performed with SPSS version
25 [IBM SPSS Statistics for Windows,
Armonk, NY: IBM Corp.],
Results
We excluded all items about car driv-
ing, because these items included a
large number of missing values
(Table 2). Item A7 ‘sports’ had 12.1%
and item 14 ‘movies, plays’ had 10.7%
missing values and were excluded.
These missing values were a result of
a sixth answer category ‘Stopped doing
this for other reasons or not interested
in doing this’. The additional items A1
and A2 were similar to the regular
items 1 and 2, but had a divergent
number of answer categories, namely
ten instead of ﬁve, and hence were also
excluded. This resulted in 32 items for
principal component analysis (PCA).
The conﬁrmatory factor analysis
(CFA) indicated an insuﬃcient ﬁt:
CFI (0.844), TLI (0.833), RMSEA
(0.097) and SRMR (0.051). Following
the recommendations by Reeve et al.,
we then performed an exploratory
factor analysis. The explained variance
was 56.50% by the ﬁrst component
and 5.05% by the second component.
Fig. 1. Schematic presentation of the VFQ-3oo7. Rasch analysis allows expressing the respon-
dents’ performance on the same latent trait as the item measure. First item A11b, in the middle of
the latent trait, is administered. Depending on the answer, the respondent is routed through the
questionnaire. Every arrow represents an answer category, and the split is determined by the
median of the item. In the end, only three out of the seven items could be used, where the answers
navigate patients to a ﬁtting trait level.
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The following eigenvalues for the ﬁrst
four components were as follows:
18.08; 1.62; 1.30 and 1.01, respectively.
The Monte Carlo PCA parallel anal-
ysis suggested that the ﬁrst eigenvalue
should be at least 1.187, the second
1.164, the third 1.147 and the fourth
1.13. Thus, according to this criterion
a second and third factor might be
present. However, the solution with
two components resulted in one pain
item (item 4). The three component
solution included the two items on
pain only in the third component
(items 4 and 19), where the second
component was entirely recessive. For
this reason, we continued with the
one-component solution, and the sec-
ond and third components were not
suitable. This one-component solution
yielded two items with a too low
component loading (<0.50); item 1 on
the general health state (0.39), and
item 4 on pain and discomfort around
the eyes (0.29, Table 2). Therefore, 30
items were selected for gPCM analy-
ses. These 30 items had a person
separation index of 3.79, a person
reliability index of 0.93 and a Cron-
bach’s alpha of 0.975.
Ordering of the items on the basis of
the latent trait, classiﬁcation and
selection of the most discriminating
items per class, resulted in the selection
of the items 2, A3, 17, A11b, 24, 11 and
A9 (Table 3).
Fit statistics
The item inﬁt mean square measure
for the 30 item gPCM analysis
was 1.08 and the outﬁt measure was
0.90. For the seven-item analysis (in-
cluding all scored categories), these
measures were respectively 1.04 and
0.91. All these measures were well
within the acceptable range of 0.70
and 1.30.
Table 2. Original NEI-VFQ-25 + 14 items, PCA loadings and number of missing values.
Item Text PCA loading Percent missing values
1 General health 0.392 0.8%
2 Present eyesight 0.677 1.6%
3 Worry about eyesight 0.593 0.2%
4 Pain or discomfort 0.285 0.2%
5 Diﬃculty reading ordinary print in newspapers 0.820 0.4%
6 Diﬃculty with work or hobbies 0.798 1.4%
7 Diﬃculty ﬁnding something on a crowded shelf 0.820 0.6%
8 Diﬃculty reading street signs or the names of stores 0.813 0.9%
9 Diﬃculty going down steps, stairs, or curbs in dim light or at night 0.755 1.3%
10 Diﬃculty noticing objects oﬀ to the side while walking along 0.742 1.0%
11 Diﬃculty seeing how people react to things you say 0.825 0.9%
12 Diﬃculty picking out and matching clothes 0.734 1.5%
13 Diﬃculty visiting people in their homes, at parties, or in restaurants 0.779 1.4%
14 Diﬃculty going out to see movies, plays, or sports events 10.7%
15 Are you currently driving, at least once in a while? 0.9%
15a If no: have you never driven a car or have you given up driving? 66.3%*
15b If you gave up driving: Was that mainly because of eyesight? 86.2%*
15c If currently driving: diﬃculty driving during daytime in familiar places 35.4%*
16 Diﬃculty driving at night 37.2%*
16a Diﬃculty driving in diﬃcult conditions 36.4%*
17 Do you accomplish less than you would like because of your vision? 0.792 0.5%
18 Limited in how long you can work or do other activities? 0.774 1.0%
19 Pain or discomfort keeps you from doing what you’d like to be doing 0.541 0.6%
20 Stay home most of the time because of eyesight 0.722 0.3%
21 Frustrated a lot of the time because of eyesight 0.793 0.5%
22 Much less control, because of eyesight 0.840 0.4%
23 Because of eyesight, I must rely too much on what other people tell 0.835 0.4%
24 I need a lot of help from others because of my eyesight 0.854 0.6%
25 I worry about doing things that will embarrass myself or others 0.752 0.6%
A1 How would you rate your overall health, on a 0-10 scale? 1.9%
A2 How would you rate your eyesight now, on a 0-10 scale? 1.2%
A3 Diﬃculty reading small print on a medicine bottle, or on legal forms 0.749 1.5%
A4 Diﬃculty ﬁguring out whether bills you receive are accurate 0.839 2.4%
A5 Diﬃculty shaving, styling your hair, or putting on makeup 0.759 2.8%
A6 Diﬃculty recognizing people from across a room 0.802 1.6%
A7 Diﬃculty in active sports or other outdoor activities you enjoy 12.1%
A8 Diﬃculty seeing and enjoying programs on TV 0.814 1.6%
A9 Diﬃculty entertaining friends and family in your home 0.763 1.9%
A11a Do you have more help from others because of your vision? 0.812 1.4%
A11b Limited in the kinds of things you can do because of your vision? 0.861 1.4%
A12 I am often irritable because of my eyesight 0.694 2.2%
A13 I don’t go out of my home alone, because of my eyesight 0.682 2.3%
Shaded items are included in Rasch analysis.
PCA = principal component analysis.
* These high missing values are partly a result of the limited amount drivers among the respondents.
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Differential item functioning (DIF)
Item 2, which was the ﬁrst item at the
best seeing side of the latent variable,
showed DIF for uveal melanoma
patients (adjusted t-value = 2.94;
p = 0.003). For these patients, this item
was ranked second, while this item was
far on the well seeing side for the other
six populations. Note that there were
49 DIF tests applied (seven items times
seven eye disorders). A Bonferroni
correction would result in a corrected
signiﬁcance level of p = 0.001.
Multilevel structure
The mean absolute diﬀerence (MAD)
for the total sample was 0.130, thus
lower than 1.96 times the standard
error (1.96*0.073 = 0.142). The MADs
were larger for retinal detachment
Table 3. Items in GPCM model sorted by item measure and categorized in seven categories.
Item
Item
measure
Discriminative
value Original domains
Pesudovs Two scale
approach Kowalski Fukuhara
2 2.95 1.00 General vision V11† †
3 1.95 0.54 Mental
A3 1.75 0.95 Near V15* †
6 1.09 1.13 Near V12† † †
17 1.08 1.18 Role S12† * †
9 0.95 0.89 Distance V13†
5 0.91 1.07 Near V14† †
18 0.74 1.01 Role S10† †
A11b 0.49 1.33 Role S9* *
8 0.36 1.06 Distance V10† †
10 0.32 0.87 Peripheral V7*
22 0.29 1.11 Mental S11† *
21 0.12 0.94 Mental
A8 0.04 1.11 Distance V6* †
A11a 0.12 1.09 Role S4* *
7 0.22 1.15 Near V9† *
A4 0.26 1.13 Near V4* *
A12 0.29 0.72 Mental
19 0.37 0.25 Pain
23 0.56 1.11 Dependent S8† *
A6 0.61 1.06 Distance V3* †
24 0.63 1.18 Dependent S6* †
A5 0.66 0.93 Near V2*
11 0.72 1.16 Social S3* † †
25 1.12 0.98 Mental S7† † †
20 1.18 0.93 Dependent S5† † *
13 1.24 1.11 Social S1† *
12 1.34 1.02 colour V1* *
A9 1.80 1.17 Social
A13 1.92 1.02 Dependent S2*
Shaded items have the highest discriminative value in a category and are included in the ﬁnal selection for the VFQ-3oo7. Pesudovs and Kowalski
selected item 14, which we did not take into account because of >10%missing values. Pesudovs also selected A7, which had also >10%missings in our
sample. Two scale approach of Pesudovs: V = Visual functioning and S = Socio-emotional item. Both items were ordered by severity.
GPCM = generalized partial credit model.
* First selection by Pesudovs, Fukuhara and Kowalski.
† Final selection by Pesudovs, Fukuhara and Kowalski.
Table 4. Precision of various selections of the NEI-VFQ-25, based on our macular degeneration
sample.
Scale Method
Number
of items
Macular degeneration
t-value
Relative
precision
VFQ-32 Likert 32 4.539 100.0
Rasch 32 5.366 118.2
VFQ-3oo7* 3 3.940 86.8
VFQ-7† Likert 7 4.806 105.9
Rasch 7 4.919 108.4
Fukuhara Likert 11 4.927 108.6
Rasch 11 5.585 123.1
Kowalsky Likert 6 2.460 54.2
Rasch 6 3.284 72.4
Pesudovs-visual
function scale
Likert 6 4.912 108.2
Rasch 6 5.098 112.3
Pesudovs-socio-
emotional scale
Likert 7 2.435 53.7
Rasch 7 2.894 63.8
* The VFQ-3oo7 has a weighted sum score that is derived from Rasch analyses.
† These are all the 7 items applied in the VFQ-3oo7 without routing.
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(0.161; CI < 0.403), glaucoma (0.172:
CI < 0.214) and uveal melanoma
(0.173; CI < 0.243), and smaller for
corneal disease (0.101; CI < 0.292) and
macular degeneration (0.100;
CI < 0.212), but the same held for the
standard errors. Within each patient
group, the MADs were within accept-
able conﬁdence limits.
Precision
We applied our data on the treatment
of macular degeneration for the preci-
sion analyses, as this was our largest
sample with at least two measurements.
We had 336 baseline measures and 285
follow-up measures. Rasch scoring
performed better than Likert scoring
for all selections (Table 4). The selec-
tion of 11 items by Fukuhara et al.
(2013) yielded the largest relative pre-
cision, followed by the visual function
scale of Pesudovs, the VFQ-3oo7 and
the selection of Kowalsky.
Disorder-specific analyses
Rasch analyses within the data of the
diﬀerent eye disorders generally led to
other selections of items. In the
retinal detachment sample, the solu-
tion yielded a correlation of 0.928,
which was 0.005 higher than the
general solution in this sample
(r = 0.923). In all other samples, the
sample-speciﬁc solution led to a lower
correlation than the overall
solution.
Routing of the VFQ-3oo7
The ﬁrst item presented to every
patients was item A11b ‘Are you lim-
ited in the kinds of things you can do
because of your vision’? as it is in the
middle of the latent trait (Fig. 1).
Answer category ‘a’ led to item A3,
where categories ‘b’ to ‘e’ led to item
11. Categories ‘a’ and ‘b’ on item A3
led to item 2, and categories ‘c’ to ‘e’
led to item 17. Category ‘a’ on item 11
led to item 24 and categories ‘b’ tot ‘e’
led to item A9.
Item weights for calculating the VFQ-
3oo7 score
The optimal weights gained from the
iterative procedure are presented in
Fig. 2. This solution resulted in a
correlation of 0.924 with the person
measures of the 30-item gPCM.
Discussion
Principal findings
The main goal of this study, to reduce
the number of items for routine use of
PROMs in regular care, is particularly
important for patients with eye disor-
ders. First, problems with eyesight may
cause more diﬃculty in answering
questionnaires. Second, they represent
mainly an elderly population, having a
higher comorbidity. A higher comor-
bidity in turn demands more follow-up
visits and treatments, with more fre-
quent PROM questionnaires as a con-
sequence. Hence, these patients are
probably more subject to respondent
burden.
This study reduced the number of
items of the NEI-VFQ-25, including
additional items, from 39 to the prede-
termined three administered items out
of seven. A one-dimensional structure
was considered ﬁtting. During the item
selection, ﬁve items were removed due
to a large number of missing values and
two items were removed as a result of
similarity to other items. Two other
items showed too low component load-
ings and were therefore excluded. The
last step of reducing the remaining 30
items to seven items was accomplished
by Rasch analysis. By routing, only
three items out of the seven need to be
administered. The VFQ-3oo7 showed a
small loss of information compared
with the total score of the NEI-VFQ-
25: correlation 0.927 and a relative
precision of 0.868.
Our principal findings in relation to the
existing literature
Successfully shortened versions of the
NEI-VFQ-25 have been produced ear-
lier. However, our aims were more
rigorous in reducing the number of
items to as few as 3 out of 7; in
addition, our methods diﬀered from
those used before. In concordance with
Fukuhara et al. (Fukuhara et al. 2013),
we also excluded the three driving
items. They used a scree plot and
eigenvalue criterion to distinguish the
number of dimensions, which more or
less matched our uni-dimensionality
criteria 2 and 3, namely the ﬁrst
Fig. 2. Visual presentation and calculation of the VFQ-3oo7. The upper left symbol starts at
1.145. Then, 0.085 times the response on the ﬁrst item (A11b) is subtracted. When this ﬁrst
response is 1, the next question is A3, and 0.043 times the response on A3 is subtracted. The same
procedure holds for the third question. When the response on the ﬁrst question is larger than 1, the
second question is 11, and subsequently 0.104 times the response on this question is subtracted.
Then, the third question follows in the same way. Note that the scale is not linear, but a logit scale.
The routing is based on medians, therefore question A9 is most frequent.
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eigenvalue should be at least ﬁve times
higher than the second eigenvalue, and
items should load at least 0.50 on the
ﬁrst component. For item selection, a
more stringent criterion was applied
than in previous studies (Pesudovs
et al. 2010; Fukuhara et al. 2013),
which used a loading of 0.40, with an
explained variance of 0.402 = 16%. A
loading of 0.50, indicating an explained
variance of 25%, will provide more
reliable items.
Fukuhara et al. (2013) and Kowalski
et al. (2012) intended to retain informa-
tion on all domains, and therefore
included at least one item on the domains
general vision, near activities, distant
activities, vision-speciﬁc social function-
ing, vision-speciﬁc mental health, vision-
speciﬁc role diﬃculties and vision-speciﬁc
dependency (Table 3). Our study did not
aim to include every domain, but to
retain the largest range as possible of the
visual spectrum. The result is that we did
not include items for the distant activity
and mental health domains.
Pesudovs et al. (2010) discerned two
scales: a visual functioning scale and a
socio-emotional scale. In our data, we
did not ﬁnd a socio-emotional dimen-
sion. When we evaluated the two and
three component analyses, these com-
ponents only included the two items on
pain (items 4 and 19).
The precision analyses showed that
the selection of Fukuhara et al. (2013)
distinguished best between the mea-
surements in our data of patients with
macular degeneration. It must be noted
that they also used the most items.
Fewer items obviously lead to a lower
precision. The six items that are
selected for Pesudovs’ vision scale per-
form virtually as well as all 32 items.
However, Pesudovs’ social scale per-
forms much less in this population. It
may be that it better performs in other
patient populations. Also, Kowalski’s
selection does not perform very well in
this population. The VFQ-3oo7 per-
forms less than the selections of Fuku-
hara and Pesudovs. This imprecision is
likely to be the price for the large
reduction of items, if the relative pre-
cision would also be calculated relative
to the number of items, the VFQ-3oo7
would score best.
Limitations
Item 2 ‘present sight’ showed margin-
ally signiﬁcant DIF in the uveal
melanoma patients. Generally, the item
at the best seeing end of the continuum
was present sight. However, in the
uveal melanoma population, item 3
‘worry about eyesight’ was the item
that was most sensitive at the best
seeing end. Patients with uveal mela-
noma experience not so much visual
problems but have other worries. This
may be explained by the dooming and
worrisome nature of uveal melanoma
and carcinoma in general, as there is a
signiﬁcant risk of losing an eye or even
worse, die. Apparently, and logically,
item 2 of the VFQ-3oo7 had a slightly
diﬀerent meaning for the uveal mela-
noma patients, as these patients expe-
rience less visual problems. This
indicates that the VFQ-3oo7 may be
less sensitive for uveal melanoma
patients with mild visual problems.
A inevitable consequence of our aim
to reduce the VFQ-25 to only three
questions to be answered is that it
excludes the possibility to cover all
original subscales. For speciﬁc eye
disorders, it can be appropriate to
add one or a few relevant items con-
sidered indispensable, that is for glau-
coma patients the item on pain can be
added, in particular, because pain was
hardly represented in the one-compo-
nent solution.
Future perspectives
In this study, we focused on shortening
an instrument to measure vision-related
health status. However, at least for
some eye disorders, additional perceived
outcome domains may be relevant. For
example for glaucoma, the burden/side
eﬀects of treatment have been identiﬁed
as a relevant outcome domain (Somner
et al. 2012). For speciﬁc eye disorders,
future studies should focus on identify-
ing additional domains and items, while
preserving the requirement of a very
short instrument.
The latest development in Rasch
includes computer adaptive testing
(CAT) in the clinical application. This
creates interesting possibilities, but one
needs to employ a full CAT infrastruc-
ture. With the methodology presented
here, such CAT infrastructure is not
necessary and thus the VFQ3oo7 can
be employed more easily. With the
VFQ-3oo7, ophthalmologists have a
user-friendly tool to monitor the
patients’ perspective on their visual
functioning in regular care. The use of
the VFQ-3oo7 oﬀers possibilities to
explore the patients’ perspective, with-
out the cumbersome administration of
the long original NEI-VFQ-25. In our
hospital, the VFQ-3oo7 is now imple-
mented. Patients ﬁll in the computer-
based questionnaire before each con-
sultation. The outcome is directly pre-
sented in the electronic patient ﬁle and
visible to the ophthalmologist. It is
most appreciated in the clinical com-
munication when clinical outcomes
contradict with the outcome of the
VFQ3oo7 or when the outcome of the
VFQ-3oo7 shows signs of improve-
ment or deteriorations over time. It is
up to the ophthalmologist to use the
outcome of the vfq3oo7. This could aid
the dialogue between ophthalmologists
and patients, and could help to sub-
stantiate a referral to low vision spe-
cialists or psychologists.
Conclusions
The goal of this study was to reduce the
number of NEI-VFQ-25 items to seven
items of which three are to be admin-
istered by the patient while retaining a
high distinctive capacity, to make it
suitable for routine PROM measure-
ment in clinical practice. Correlating
0.927 with the criterion, the VFQ-3oo7
has succeeded in realizing this goal. The
VFQ-3oo7 also appeared suitable for
various eye disorders. The very short,
but valid, VFQ-3oo7 can be applied to
evaluate the patient’s perceived vision-
related health status in routine evalua-
tions of treatments in regular care, with
only little burden for patients.
Data availability
statement
The VFQ 3oo7 can also be administered
on paper, and scored by means of an
Excel ﬁle that is digital available on
request.
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